Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors
Article in Clinical Cancer Research (January 2019)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (January 2019)
Article in Clinical Cancer Research (November 2014)
Article in Nature Reviews Gastroenterology & Hepatology (July 2007)